When a company collects a prestigious industry designation, secures fresh government funding, and reports usage numbers that would make any tech firm envious, the natural expectation is a rising stock price. D-Wave Quantum has delivered all three in a single week. The shares, however, have gone in the opposite direction, closing Friday at €17.59 with a daily loss of 5.28%. The weekly decline stands at 11.68%, marking the worst five-day stretch in over a month.
The gap between corporate achievement and market reception has rarely been wider. The IDC MarketScape for quantum computing vendors placed D-Wave among just two leadership-tier companies, citing commercial traction across manufacturing, telecommunications, logistics, and defence. Behind that accolade lies real operational momentum: customers have submitted more than 200 million problems to D-Wave’s systems, usage of the Advantage2 platform surged 314% year-over-year, and activity on the Stride hybrid solver jumped 114% in six months. For most growth-stage companies, such metrics would be enough to support a narrative of accelerating adoption.
Washington has also taken notice. The National Science Foundation awarded D-Wave a $1.57 million grant through its National Quantum Virtual Laboratory programme, funding the company’s role in the ERASE project – a Yale-led initiative focused on fault-tolerant quantum computing. CEO Alan Baratz framed the award as a strategic nod to the national importance of scalable quantum systems. And the bigger prize still looms: the US Department of Commerce is advancing a roughly $2 billion quantum funding package for nine selected companies, and D-Wave has signed a binding letter of intent to receive a share. The funds would support research hubs in Boca Raton, New Haven, and Burnaby.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Yet the stock remains stubbornly range-bound. At €17.59, D-Wave trades 54.30% below its 52-week high of €38.48 from October and 15.06% beneath its 50-day moving average of €20.70. It also sits 14.63% under the 200-day average, though almost exactly on the 100-day line at €17.91. That clustering around a single average hints at a genuine consolidation phase rather than a directional breakdown. The relative strength index, at 39.0, suggests the stock is approaching oversold territory, but annualised 30-day volatility of 89.69% means calm is not on the horizon.
For all the recent pain, the longer picture is less bleak. Over the past twelve months, D-Wave still shows a gain of 28.40%. The year-to-date loss of 26.76% and the monthly decline of 12.77% reflect how much of that earlier rally has been unwound, particularly for investors who piled in during the autumn euphoria. The current market capitalisation of €6.68 billion places D-Wave among the mid-cap quantum proxies, where sentiment often moves faster than fundamentals.
Analysts, at least, remain bullish. The average price target of €32.73 implies roughly 86% upside from Friday’s close. That optimism can be read in two ways: either the sell-side sees genuine commercial value that current prices have discounted too heavily, or the models are simply lagging a stock that has become a pure play on sector-wide mood swings. Given the recent price action, the latter explanation carries weight. Government grants and industry awards buy attention, but they have not yet bought the stability that would convince short-term traders to stay put.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from July 11 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 11.
D-Wave Quantum: Buy or sell? Read more here...
